Comparison between Vrushadi Vati and Tab Clomiphene citrate in treatment of Kshina Shukra (Oligospermia)

Evaluation of Comparative Efficacy of Vrushadi Vati Versus Tab Clomiphene citrate in the Management of Kshina Shukra (Oligospermia)- RCT - Nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/12/060837

Enrollment

Registered

2023-12-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in the study and give written informed consent Patients should be male and Age between the ages of 21to50 Years Patients having spermatozoa 10 to 20 million sperm per milliliter of semen. Patients having Habit of smoking and Alcohol.

Exclusion criteria

Exclusion criteria: Current treatment with Antihypertensive medication and Diabetic Mellitus Subjects who have significant Heart disease and Congenital Disorders History of neurological disorder and Systemic disorder Tuberculosis Venereal diseases mumps Homosexual person Patient with Azoospermia Aspermia Hyperspermia Teratozoospermia Necrospermia Subjects with history of significant Central nervous system injuries including stroke or spinal cord injury

Design outcomes

Primary

Measure	Time frame
Effect of Vrushadi Vati in increase Sperm Count & MotilityTimepoint: 90 days	—

Secondary

Measure	Time frame
Increase strength of a personTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Sourabh Deshmukh

Mahatma Gandhi Ayurved College Hospital and Research centre

ayurrulz@gmail.com9404337799

Outcome results